RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 28227
 
  
 
C07K PEPTIDES 16120
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 13193
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 594
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 4163
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 4121
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 2105
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 297
 
  
 
G02B OPTICAL ELEMENTS, SYSTEMS, OR APPARATUS 1204
 
  
 
B82Y SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE  OR TREATMENT OF NANO-STRUCTURES152

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0055,907 COMPOSITIONS COMPRISING SEMAPHORINS FOR THE TREATMENT OF CANCER AND METHODS OF SELECTION THEREOFNov 05, 17Mar 01, 18[A61K, G01N]
2017/0247,422 EXTRACELLULAR MATRIX METALLOPROTEINASE INDUCER (EMMPRIN) PEPTIDES AND BINDING ANTIBODIESMay 16, 17Aug 31, 17[C12N, G01N, C07K]
2017/0072,019 COMPOSITIONS COMPRISING IL-31 AND USES THEREOFMay 12, 15Mar 16, 17[A61K, C07K]
2015/0290,283 LIGHT-SENSITIVE PUMPS FOR SUPPRESSION OF CARDIAC ACTIVITYOct 07, 13Oct 15, 15[A61K, A61N]
2015/0290,285 LIGHT-SENSITIVE ION CHANNELS FOR INDUCTION OF CARDIAC ACTIVITYOct 31, 13Oct 15, 15[A61K, A61N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9896490 Semaphorin 3C variants, compositions comprising said variants and methods of use thereofSep 07, 14Feb 20, 18[A61K, C07K]
9808506 Compositions comprising semaphorins for the treatment of cancer and methods of selection thereofSep 08, 15Nov 07, 17[A61K, G01N, C07K]
9717777 Use of CCL1 in therapyMay 25, 16Aug 01, 17[A61K, C07K]
9688732 Extracellular matrix metalloproteinase inducer (EMMPRIN) peptides and binding antibodiesSep 30, 14Jun 27, 17[A61K, C12N, G01N, G06F, C07K]
9670282 Compositions and methods for diagnosing and treating an inflammationMay 18, 16Jun 06, 17[A61K, G01N, C07K]
9611324 Compositions and methods for diagnosing and treating an inflammationApr 16, 15Apr 04, 17[A61K, G01N, C07K]
9518993 Reagents and methods for detecting a polymorphic proteinNov 03, 14Dec 13, 16[G01N, C07K]
9371385 Compositions and methods for diagnosing and treating an inflammationAug 18, 15Jun 21, 16[A61K, G01N, C07K]
9352000 Use of CCL1 in therapyMay 05, 11May 31, 16[A61K, C12N, C07K]
9155781 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereofJul 15, 13Oct 13, 15[A61K, G01N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0175,364 TROPHOBLAST DERIVED MICROPARTICLES FOR TREATING ISCHEMIC TISSUE AND WOUNDSAbandonedJul 28, 14Jun 23, 16[A61K]
2013/0330,349 HIGH AFFINITY MOLECULES CAPABLE OF BINDING A TYPE A PLEXIN RECEPTOR AND USES OF SAMEAbandonedFeb 23, 12Dec 12, 13[A61K, C07K]
8486641 Compositions and methods for diagnosing and treating prostate cancerExpiredMay 24, 10Jul 16, 13[G01N]
2012/0129,183 METHODS AND KITS FOR ISOLATING PLACENTAL DERIVED MICROPARTICLES AND USE OF SAME FOR DIAGNOSIS OF FETAL DISORDERSAbandonedJun 24, 10May 24, 12[C12Q, G01N]
2012/0095,107 METHODS FOR TREATMENT OF CARDIOVASCULAR DISORDERS AND DISEASESAbandonedDec 23, 11Apr 19, 12[A61K, A61P]
2011/0301,186 USE OF HAPTOGLOBIN GENOTYPING IN DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASEAbandonedAug 04, 11Dec 08, 11[A61K, C12Q, G01N, A61P]
2011/0288,013 GLYCEMIC CONTROL FOR REDUCTION OF CARDIOVASCULAR DISEASE RISK IN DIABETIC PATIENTS EXPRESSING HAPTOGLOBIN 2-2AbandonedAug 04, 11Nov 24, 11[A61K, C12Q, G01N, A61P]
2011/0142,857 METHODS OF ALTERING PERIPHERAL B CELL POPULATIONS AND USES THEREOFAbandonedJul 19, 09Jun 16, 11[A61K, A61P]
2011/0044,945 AGENTS FOR THE TREATMENT OF MULTIPLE SCLEROSIS AND METHODS OF USING SAMEAbandonedFeb 06, 08Feb 24, 11[A61J, A61K, A61P]
2009/0246,770 GLYCEMIC CONTROL FOR REDUCTION OF CARDIOVASCULAR DISEASE RISK IN DIABETIC PATIENTS EXPRESSING HAPTOGLOBIN 2-2AbandonedOct 31, 08Oct 01, 09[C12Q]
2009/0197,286 Methods and Kit for Diagnosing T1DMAbandonedFeb 06, 07Aug 06, 09[G01N]
2009/0137,617 USE OF HAPTOGLOBIN GENOTYPING IN DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASEAbandonedNov 24, 08May 28, 09[A61K]
7507788 Peptides and methods for cell death regulationExpiredMay 08, 03Mar 24, 09[C07K]
2009/0074,740 Use of haptoglobin genotyping in diagnosis and treatment of defective reverse cholesterol transport (RCT)AbandonedMay 14, 08Mar 19, 09[A61K, C12Q]
2009/0054,322 Polypeptides and compositions comprising same and methods of using same for treating cxcr4 associated medical conditionsAbandonedMay 25, 06Feb 26, 09[A61K, C07H, A61P, C07K]
2009/0042,217 Methods and Kits for Determining Blood CoagulationAbandonedJun 23, 08Feb 12, 09[C12Q, G01N]
2008/0234,283 Glutathione peroxidase mimetics for treatment of neurodegenerative, pulmonary and inflammatory diseasesAbandonedFeb 19, 08Sep 25, 08[A61K, A61P]
2008/0213,785 Method of predicting a benefit of antioxidant therapy for prevention or treatment of vasclar disease in hyperglycemic individualsAbandonedFeb 19, 08Sep 04, 08[C12Q]
2008/0090,915 METHOD FOR PREVENTING OR ATTENUATING ANTHRACYCLINE-INDUCED CARDIOTOXICITYAbandonedOct 18, 07Apr 17, 08[A61K, A61P]
2008/0044,399 Vitamin E supplementation for reducing cardiovascular events in individuals with DM and the Hp 2-2 genotypeAbandonedMay 14, 07Feb 21, 08[A61K, C12Q, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.